SCHEMBL7270127

SCHEMBL7270127

CC(C)[C@H](N)C(=O)N(C(=O)OCc1ccccn1)C(Cc1ccccc1)C(O)C(Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.53
CTSD P07339 4/20 0.51
REN P00797 2/20 0.42
CASP3 P42574 1/20 0.42
CASP7 P55210 1/20 0.42
BACE1 P56817 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
PSMB11 A5LHX3 1/20 0.39
PSMA7 O14818 1/20 0.39
PSMB1 P20618 1/20 0.39
PSMA1 P25786 1/20 0.39
PSMA2 P25787 1/20 0.39
PSMA3 P25788 1/20 0.39
PSMA4 P25789 1/20 0.39
PSMB8 P28062 1/20 0.39
PSMB9 P28065 1/20 0.39
PSMA5 P28066 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449614 0.91 CTSD (0.53) CA2CTSDRENCASP3BACE1
SCHEMBL7275766 0.89 CTSD (0.51) CA2CTSDRENBACE1CTSL
SCHEMBL7270130 0.85 CA2 (0.64) CA2CTSDRENCASP3CASP7
SCHEMBL7275895 0.85 PGR (0.47) CA2CYP1A2CYP2D6TSHRSMN1; SMN2
SCHEMBL7270084 0.85 CTSD (0.53) CTSDRENBACE1CTSLCTSB
SCHEMBL6447678 0.85 PGR (0.46) CA2CYP1A2CYP2D6TSHRSMN1; SMN2
SCHEMBL6445021 0.85 PGR (0.46) CA2CYP1A2CYP2D6TSHRSMN1; SMN2
SCHEMBL6449059 0.85 PGR (0.46) CA2CYP1A2CYP2D6TSHRSMN1; SMN2
SCHEMBL7269005 0.84 CTSD (0.53) CA2CTSDRENCASP3BACE1
SCHEMBL6445023 0.84 CA2 (0.69) CA2CTSDRENCASP3CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed